• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡托普利-聚乙烯亚胺共轭修饰的金纳米粒子用于抗血管生成乳腺癌治疗中药物和基因的共递送

Captopril-polyethyleneimine conjugate modified gold nanoparticles for co-delivery of drug and gene in anti-angiogenesis breast cancer therapy.

作者信息

Li Manhong, Li Yong, Huang Xiaohui, Lu Xizhi

机构信息

a Department of Pathology , The First Affiliated Hospital of Shantou University Medical College , Shantou 515041 , China.

出版信息

J Biomater Sci Polym Ed. 2015;26(13):813-27. doi: 10.1080/09205063.2015.1057991. Epub 2015 Jul 13.

DOI:10.1080/09205063.2015.1057991
PMID:26166244
Abstract

Captopril-polyethyleneimine (CP) containing low molecular weight polyethyleneimine and anti-angiogenesis drug captopril conjugated via an amide bond was fabricated to modify gold nanoparticles and complex with siRNA to construct siRNA/CP/GNP complexes for the co-delivery of drug and siRNA in anti-angiogenesis breast cancer therapy. The self-assembled siRNA/CP/GNP complexes exhibited desirable and homogenous particle size, reasonable positive charges and condensation ability, and effective gene-silencing property in vitro. In addition, siRNA/CP/GNP complexes co-delivering captopril and siRNA achieved combined angiogenesis suppression by more effectively downregulating the expression of vascular endothelial growth factor mRNA and protein via different pathways in vitro, as compared to mono-delivery systems. In vivo investigation on nude mice bearing MDA-MB435 tumor xenografts revealed that siRNA/CP/GNP complexes possessed satisfying tumor homing ability and strong antitumor activity. These findings suggested that siRNA/CP/GNP complexes could be an ideal system for simultaneous transfer of drug and siRNA, which might be a new promising strategy for effective breast cancer therapy.

摘要

制备了含有低分子量聚乙烯亚胺和通过酰胺键与抗血管生成药物卡托普利共轭的卡托普利-聚乙烯亚胺(CP),用于修饰金纳米颗粒并与siRNA复合,构建siRNA/CP/GNP复合物,用于在抗血管生成乳腺癌治疗中共同递送药物和siRNA。自组装的siRNA/CP/GNP复合物在体外表现出理想且均匀的粒径、合理的正电荷和凝聚能力以及有效的基因沉默特性。此外,与单递送系统相比,共同递送卡托普利和siRNA的siRNA/CP/GNP复合物通过在体外不同途径更有效地下调血管内皮生长因子mRNA和蛋白质的表达,实现了联合血管生成抑制。对携带MDA-MB435肿瘤异种移植物的裸鼠进行的体内研究表明,siRNA/CP/GNP复合物具有令人满意的肿瘤归巢能力和强大的抗肿瘤活性。这些发现表明,siRNA/CP/GNP复合物可能是药物和siRNA同时转移的理想系统,这可能是有效乳腺癌治疗的一种新的有前景的策略。

相似文献

1
Captopril-polyethyleneimine conjugate modified gold nanoparticles for co-delivery of drug and gene in anti-angiogenesis breast cancer therapy.卡托普利-聚乙烯亚胺共轭修饰的金纳米粒子用于抗血管生成乳腺癌治疗中药物和基因的共递送
J Biomater Sci Polym Ed. 2015;26(13):813-27. doi: 10.1080/09205063.2015.1057991. Epub 2015 Jul 13.
2
A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy.壳聚糖接枝聚醚酰亚胺-坎地沙坦偶联物用于抗血管生成癌症治疗中药物和基因的靶向共递送。
Biomaterials. 2014 Sep;35(29):8450-66. doi: 10.1016/j.biomaterials.2014.06.025. Epub 2014 Jul 3.
3
Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.通过重建的高密度脂蛋白直接胞质内递送 siRNA 用于肿瘤血管生成的靶向治疗。
Biomaterials. 2014 Aug;35(25):7214-27. doi: 10.1016/j.biomaterials.2014.05.009. Epub 2014 May 27.
4
Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.低分子量聚亚乙基亚胺交联 2-羟丙基-β-环糊精和叶酸作为高效无毒的 siRNA 载体,通过 VEGF siRNA 抑制基因表达和肿瘤生长。
Int J Nanomedicine. 2013;8:2101-17. doi: 10.2147/IJN.S42440. Epub 2013 Jun 5.
5
Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.聚(山梨醇-co-聚乙烯亚胺)介导的骨桥蛋白小干扰RNA对肺癌异种移植模型小鼠肿瘤生长的抑制作用
Eur J Pharm Biopharm. 2015 Aug;94:450-62. doi: 10.1016/j.ejpb.2015.06.017. Epub 2015 Jun 30.
6
Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.采用 PEI-PEG-APRPG 聚合物的小干扰 RNA 递药系统用于抗血管生成血管内皮生长因子肿瘤靶向治疗。
Int J Nanomedicine. 2011;6:1661-73. doi: 10.2147/IJN.S22293. Epub 2011 Aug 11.
7
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.采用 CD44 靶向壳聚糖纳米粒将 PLXDC1 小干扰 RNA 选择性递送至内皮细胞用于上皮性卵巢癌的抗血管生成肿瘤治疗。
Drug Deliv. 2018 Nov;25(1):1394-1402. doi: 10.1080/10717544.2018.1480672.
8
Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.体内的聚乙烯亚胺/小干扰 RNA 介导的血管内皮生长因子敲低与贝伐单抗联合使用具有协同的抗肿瘤作用。
J Gene Med. 2010 Mar;12(3):287-300. doi: 10.1002/jgm.1431.
9
[Silence of VEGFR2 expression mediated by PEI/siRNA complexes].[由聚乙烯亚胺/小干扰RNA复合物介导的血管内皮生长因子受体2表达沉默]
Yao Xue Xue Bao. 2010 May;45(5):576-81.
10
Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.利用单纳米颗粒共递送 VEGF 和 Bcl-2 双重靶向 siRNA 聚合物,在体内产生协同抗癌效果。
J Control Release. 2015 Dec 28;220(Pt B):631-41. doi: 10.1016/j.jconrel.2015.08.032. Epub 2015 Aug 23.

引用本文的文献

1
Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer.siRNA 的治疗递送在乳腺癌和三阴性乳腺癌治疗中的应用。
Ther Deliv. 2024;15(11):871-891. doi: 10.1080/20415990.2024.2400044. Epub 2024 Sep 25.
2
Synthesis of vancomycin functionalized fluorescent gold nanoparticles and selective sensing of mercury (II).万古霉素功能化荧光金纳米颗粒的合成及汞(II)的选择性传感
Front Chem. 2023 Aug 1;11:1238631. doi: 10.3389/fchem.2023.1238631. eCollection 2023.
3
Nanoparticle drug delivery systems for synergistic delivery of tumor therapy.
用于肿瘤治疗协同递送的纳米颗粒药物递送系统。
Front Pharmacol. 2023 Feb 16;14:1111991. doi: 10.3389/fphar.2023.1111991. eCollection 2023.
4
Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy.联合抗癌治疗中核酸和小分子药物的先进策略。
Int J Biol Sci. 2023 Jan 1;19(3):789-810. doi: 10.7150/ijbs.79328. eCollection 2023.
5
Metal-based nano-delivery platform for treating bone disease and regeneration.用于治疗骨疾病和再生的金属基纳米递送平台。
Front Chem. 2022 Aug 9;10:955993. doi: 10.3389/fchem.2022.955993. eCollection 2022.
6
An Insight into GPCR and G-Proteins as Cancer Drivers.G 蛋白偶联受体(GPCR)和 G 蛋白作为癌症驱动因素的深入了解。
Cells. 2021 Nov 24;10(12):3288. doi: 10.3390/cells10123288.
7
Clinical applicability of renin-angiotensin system inhibitors in cancer treatment.肾素-血管紧张素系统抑制剂在癌症治疗中的临床适用性。
Am J Cancer Res. 2021 Feb 1;11(2):318-336. eCollection 2021.
8
Advances in nanomedicine for cancer starvation therapy.癌症饥饿疗法的纳米医学进展。
Theranostics. 2019 Oct 17;9(26):8026-8047. doi: 10.7150/thno.38261. eCollection 2019.
9
Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications.金纳米颗粒与血管生成:分子机制与生物医学应用。
Int J Nanomedicine. 2019 Sep 19;14:7643-7663. doi: 10.2147/IJN.S223941. eCollection 2019.
10
Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy.介孔硅纳米粒子递送槲皮素和阿霉素增强胃癌化疗疗效。
Int J Nanomedicine. 2018 Sep 6;13:5113-5126. doi: 10.2147/IJN.S170862. eCollection 2018.